Technology

Webinar Date/Time: Thu, Aug 14, 2025 3:30 PM EDT

Webinar Date/Time: Mon, Jul 28, 2025 11:00 AM EDT

It’s the caliber of leadership that brings teams together, demands accountability, and drives purposeful, decisive action.

The new platform integrates PCR-based diagnostic data with statistical modeling and AI to provide real-time visibility into infectious disease trends at local and global levels.

Biljana Naumovic, US President, oncology, solid tumor, Johnson & Johnson Innovative Medicine, discusses the importance of collaboration across the healthcare community to develop inclusive and effective AI solutions that enhance decision-making and patient outcomes in oncology.

The intersection of artificial intelligence and direct-to-consumer advertising presents unprecedented opportunities and evolving challenges as regulations and technologies reshape the biopharma landscape.

Prioritizing deeper customer insights helps life sciences marketers understand how to engage their HCP audiences effectively with the right message.

Research has shown a gap between the female patient experience compared to those of men.

The protection and privacy of healthcare data is a massive hurdle for the new technology to overcome.

Meeting the growing need and demand for fast information to make optimal and timely treatment decisions.

Navigating technology and regulatory shifts in pharma revenue management.

The provider hopes that this option will be a solution to the state’s primary care physician shortage.

Commissioner Markary announced the plans alongside the results of a generative AI pilot for scientific reviewers.

The pharma tech company announced a deal with Starvision to roll out its services across the network over the next five years.

Capan discusses the collaboration between AWS and EVERSANA in the first part of this two-part interview.

Sheeran continues the conversation on the collaboration between AWS and EVERSANA in the second part of this interview.

AI is transforming content reviews to focus on relevant use, not just generation.

How to maximize market-entry performance for new pharma products in an increasingly competitive launch environment.

Why a fundamental rethinking of how manufacturers engage with healthcare providers, payers, and patients is necessary in today's pharma landscape.

The Verseon CEO discusses how this advanced technology is helping to discover new drug candidates.

As the physical products we use evolve to become increasingly complex, traditional products liability frameworks may not always fit to provide remedies for harm that can result from using novel product types.

Hyfe’s CEO discusses the importance of DTx and how it can change the way certain conditions are treated.

Marcel Botha, CEO of 10XBeta, identifies the most significant technological innovations in medical device manufacturing that will be crucial for future pandemic preparedness and supply chain stability.

Matthew Yelovich, partner at Cleary Gottlieb, discusses his transition in late-2024 from working as a federal prosecutor to a role at Cleary Gottlieb, as well as how he sees the intersection of technology and law evolving in the Bay Area.

Matthew Yelovich, partner at Cleary Gottlieb, discusses some of the broader implications for corporate governance and accountability the Theranos case highlights.

Rahman discusses Google Gemini and what it could mean to the future of pharma commercialization and content development.

If used properly, AI can be a game-changer for drug development.

Key trends in healthcare communication to build trust between healthcare providers and their patients.

Jennifer Kyle, CEO and founder of Condor, explores how improving financial management directly impacts drug pricing.